Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist
A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 micro...
Gespeichert in:
Veröffentlicht in: | Biology of reproduction 1996-07, Vol.55 (1), p.68-74 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 74 |
---|---|
container_issue | 1 |
container_start_page | 68 |
container_title | Biology of reproduction |
container_volume | 55 |
creator | Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) Campbell, B.K Bramley, T.A Gutierrez, C.G Peters, A.R Webb, R |
description | A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom |
doi_str_mv | 10.1095/biolreprod55.1.68 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78314353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78314353</sourcerecordid><originalsourceid>FETCH-LOGICAL-f283t-f4cb21a6aba55d91db57d244e303ce4082adce310ca2fd49ff0952de849f0f93</originalsourceid><addsrcrecordid>eNpVkc1u1TAQhS0EKpfCA4CE5AViRS52HOdnWVVAkSqxaFlHk3h8Y-TYwXYatc_Hg-HSqwKrGZ3z6Yx1TMhrzvacdfLjYLwNuASvpNzzfd0-ITsuy65oyrp9SnaMsboQohbPyYsYfzDGK1GKE3LSNp1gNduRX1frsgSM0XhHjaNpQhpxDJjuBa-p9taa0WIRk5lXC8m4A518mL1DCk5RuyY0ztz9o3_4Y_gbCAbcYwJVeIPWLzO6dH9qQqMxRDp6l0NXv0Z7m3W9RlR0M2miQA_egfIp-MW4IqBFiP_dz76J6SV5psFGfHWcp-T686fr84vi8tuXr-dnl4UuW5EKXY1DyaGGAaRUHVeDbFRZVSiYGLFibQlqRMHZCKVWVad17rhU2OaV6U6ckvcPsbnwnyvG1M8mjmgtOMyv75tW5H6lyODbI7gOM6p-CWaGcNsfW8_-u6MPcQSrA7jRxEdM8FpUbfMXm8xh2kzAPs5gbQ4V_bZtUva8r9uMvXnANPgeDiEnfb_qmvzXnIvfGRevwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78314353</pqid></control><display><type>article</type><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</creator><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</creatorcontrib><description>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</description><identifier>ISSN: 0006-3363</identifier><identifier>EISSN: 1529-7268</identifier><identifier>DOI: 10.1095/biolreprod55.1.68</identifier><identifier>PMID: 8793060</identifier><identifier>CODEN: BIREBV</identifier><language>eng</language><publisher>Madison, WI: Society for the Study of Reproduction</publisher><subject>AGONISTAS ; AGONISTE ; Animals ; Biological and medical sciences ; Buserelin - administration & dosage ; Buserelin - pharmacology ; Cattle ; CICLO ESTRAL ; CYCLE OESTRAL ; Drug Implants ; Female ; Follicle Stimulating Hormone - metabolism ; FSH ; Fundamental and applied biological sciences. Psychology ; GENISSE ; GONADOLIBERINE ; HFS ; HORMONA LIBERADORA DE GONADOTROPINA ; HORMONAS ; HORMONE ; Hormone metabolism and regulation ; INHIBICION ; INHIBITION ; Luteinizing Hormone - metabolism ; Mammalian female genital system ; NOVILLA ; OVAIRE ; Ovarian Follicle - drug effects ; Ovarian Follicle - growth & development ; OVARIOS ; OVULACION ; OVULATION ; Ovulation - drug effects ; PROGESTERONA ; PROGESTERONE ; Progesterone - blood ; SECRECION ; SECRETION ; SERUM SANGUIN ; SUERO SANGUINEO ; Vertebrates: reproduction</subject><ispartof>Biology of reproduction, 1996-07, Vol.55 (1), p.68-74</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3163487$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8793060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creatorcontrib><creatorcontrib>Campbell, B.K</creatorcontrib><creatorcontrib>Bramley, T.A</creatorcontrib><creatorcontrib>Gutierrez, C.G</creatorcontrib><creatorcontrib>Peters, A.R</creatorcontrib><creatorcontrib>Webb, R</creatorcontrib><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><title>Biology of reproduction</title><addtitle>Biol Reprod</addtitle><description>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</description><subject>AGONISTAS</subject><subject>AGONISTE</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Buserelin - administration & dosage</subject><subject>Buserelin - pharmacology</subject><subject>Cattle</subject><subject>CICLO ESTRAL</subject><subject>CYCLE OESTRAL</subject><subject>Drug Implants</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - metabolism</subject><subject>FSH</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GENISSE</subject><subject>GONADOLIBERINE</subject><subject>HFS</subject><subject>HORMONA LIBERADORA DE GONADOTROPINA</subject><subject>HORMONAS</subject><subject>HORMONE</subject><subject>Hormone metabolism and regulation</subject><subject>INHIBICION</subject><subject>INHIBITION</subject><subject>Luteinizing Hormone - metabolism</subject><subject>Mammalian female genital system</subject><subject>NOVILLA</subject><subject>OVAIRE</subject><subject>Ovarian Follicle - drug effects</subject><subject>Ovarian Follicle - growth & development</subject><subject>OVARIOS</subject><subject>OVULACION</subject><subject>OVULATION</subject><subject>Ovulation - drug effects</subject><subject>PROGESTERONA</subject><subject>PROGESTERONE</subject><subject>Progesterone - blood</subject><subject>SECRECION</subject><subject>SECRETION</subject><subject>SERUM SANGUIN</subject><subject>SUERO SANGUINEO</subject><subject>Vertebrates: reproduction</subject><issn>0006-3363</issn><issn>1529-7268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1u1TAQhS0EKpfCA4CE5AViRS52HOdnWVVAkSqxaFlHk3h8Y-TYwXYatc_Hg-HSqwKrGZ3z6Yx1TMhrzvacdfLjYLwNuASvpNzzfd0-ITsuy65oyrp9SnaMsboQohbPyYsYfzDGK1GKE3LSNp1gNduRX1frsgSM0XhHjaNpQhpxDJjuBa-p9taa0WIRk5lXC8m4A518mL1DCk5RuyY0ztz9o3_4Y_gbCAbcYwJVeIPWLzO6dH9qQqMxRDp6l0NXv0Z7m3W9RlR0M2miQA_egfIp-MW4IqBFiP_dz76J6SV5psFGfHWcp-T686fr84vi8tuXr-dnl4UuW5EKXY1DyaGGAaRUHVeDbFRZVSiYGLFibQlqRMHZCKVWVad17rhU2OaV6U6ckvcPsbnwnyvG1M8mjmgtOMyv75tW5H6lyODbI7gOM6p-CWaGcNsfW8_-u6MPcQSrA7jRxEdM8FpUbfMXm8xh2kzAPs5gbQ4V_bZtUva8r9uMvXnANPgeDiEnfb_qmvzXnIvfGRevwA</recordid><startdate>19960701</startdate><enddate>19960701</enddate><creator>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creator><creator>Campbell, B.K</creator><creator>Bramley, T.A</creator><creator>Gutierrez, C.G</creator><creator>Peters, A.R</creator><creator>Webb, R</creator><general>Society for the Study of Reproduction</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19960701</creationdate><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><author>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-f283t-f4cb21a6aba55d91db57d244e303ce4082adce310ca2fd49ff0952de849f0f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>AGONISTAS</topic><topic>AGONISTE</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Buserelin - administration & dosage</topic><topic>Buserelin - pharmacology</topic><topic>Cattle</topic><topic>CICLO ESTRAL</topic><topic>CYCLE OESTRAL</topic><topic>Drug Implants</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - metabolism</topic><topic>FSH</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GENISSE</topic><topic>GONADOLIBERINE</topic><topic>HFS</topic><topic>HORMONA LIBERADORA DE GONADOTROPINA</topic><topic>HORMONAS</topic><topic>HORMONE</topic><topic>Hormone metabolism and regulation</topic><topic>INHIBICION</topic><topic>INHIBITION</topic><topic>Luteinizing Hormone - metabolism</topic><topic>Mammalian female genital system</topic><topic>NOVILLA</topic><topic>OVAIRE</topic><topic>Ovarian Follicle - drug effects</topic><topic>Ovarian Follicle - growth & development</topic><topic>OVARIOS</topic><topic>OVULACION</topic><topic>OVULATION</topic><topic>Ovulation - drug effects</topic><topic>PROGESTERONA</topic><topic>PROGESTERONE</topic><topic>Progesterone - blood</topic><topic>SECRECION</topic><topic>SECRETION</topic><topic>SERUM SANGUIN</topic><topic>SUERO SANGUINEO</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creatorcontrib><creatorcontrib>Campbell, B.K</creatorcontrib><creatorcontrib>Bramley, T.A</creatorcontrib><creatorcontrib>Gutierrez, C.G</creatorcontrib><creatorcontrib>Peters, A.R</creatorcontrib><creatorcontrib>Webb, R</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of reproduction</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</au><au>Campbell, B.K</au><au>Bramley, T.A</au><au>Gutierrez, C.G</au><au>Peters, A.R</au><au>Webb, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</atitle><jtitle>Biology of reproduction</jtitle><addtitle>Biol Reprod</addtitle><date>1996-07-01</date><risdate>1996</risdate><volume>55</volume><issue>1</issue><spage>68</spage><epage>74</epage><pages>68-74</pages><issn>0006-3363</issn><eissn>1529-7268</eissn><coden>BIREBV</coden><abstract>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</abstract><cop>Madison, WI</cop><pub>Society for the Study of Reproduction</pub><pmid>8793060</pmid><doi>10.1095/biolreprod55.1.68</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3363 |
ispartof | Biology of reproduction, 1996-07, Vol.55 (1), p.68-74 |
issn | 0006-3363 1529-7268 |
language | eng |
recordid | cdi_proquest_miscellaneous_78314353 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | AGONISTAS AGONISTE Animals Biological and medical sciences Buserelin - administration & dosage Buserelin - pharmacology Cattle CICLO ESTRAL CYCLE OESTRAL Drug Implants Female Follicle Stimulating Hormone - metabolism FSH Fundamental and applied biological sciences. Psychology GENISSE GONADOLIBERINE HFS HORMONA LIBERADORA DE GONADOTROPINA HORMONAS HORMONE Hormone metabolism and regulation INHIBICION INHIBITION Luteinizing Hormone - metabolism Mammalian female genital system NOVILLA OVAIRE Ovarian Follicle - drug effects Ovarian Follicle - growth & development OVARIOS OVULACION OVULATION Ovulation - drug effects PROGESTERONA PROGESTERONE Progesterone - blood SECRECION SECRETION SERUM SANGUIN SUERO SANGUINEO Vertebrates: reproduction |
title | Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A32%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20in%20the%20secretion%20of%20follicle-stimulating%20hormone%20and%20luteinizing%20hormone,%20and%20ovarian%20follicle%20development%20in%20heifers%20continuously%20infused%20with%20a%20gonadotropin-releasing%20hormone%20agonist&rft.jtitle=Biology%20of%20reproduction&rft.au=Gong,%20J.G.%20(Roslin%20Institute,%20Edinburgh,%20Roslin,%20Midlothian,%20UK.)&rft.date=1996-07-01&rft.volume=55&rft.issue=1&rft.spage=68&rft.epage=74&rft.pages=68-74&rft.issn=0006-3363&rft.eissn=1529-7268&rft.coden=BIREBV&rft_id=info:doi/10.1095/biolreprod55.1.68&rft_dat=%3Cproquest_pubme%3E78314353%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78314353&rft_id=info:pmid/8793060&rfr_iscdi=true |